Literature DB >> 8413296

Biological and biochemical activities of a chimeric epidermal growth factor-Elk receptor tyrosine kinase.

V Lhoták1, T Pawson.   

Abstract

Eph, Elk, and Eck are prototypes of a large family of transmembrane protein-tyrosine kinases, which are characterized by a highly conserved cysteine-rich domain and two fibronectin type III repeats in their extracellular regions. Despite the extent of the Eph family, no extracellular ligands for any family member have been identified, and hence, little is known about the biological and biochemical properties of these receptor-like tyrosine kinases. In the absence of a physiological ligand for the Elk receptor, we constructed chimeric receptor molecules, in which the extracellular region of the Elk receptor is replaced by the extracellular, ligand-binding domain of the epidermal growth factor (EGF) receptor. These chimeric receptors were expressed in NIH 3T3 cells that lack endogenous EGF receptors to analyze their signaling properties. The chimeric EGF-Elk receptors became glycosylated, were correctly localized to the plasma membrane, and bound EGF with high affinity. The chimeric receptors underwent autophosphorylation and induced the tyrosine phosphorylation of a specific set of cellular proteins in response to EGF. EGF stimulation also induced DNA synthesis in fibroblasts stably expressing the EGF-Elk receptors. In contrast, EGF stimulation of these cells did not lead to visible changes in cellular morphology, nor did it induce loss of contact inhibition in confluent monolayers or growth in semisolid media. The Elk cytoplasmic domain is therefore able to induce tyrosine phosphorylation and DNA synthesis in response to an extracellular ligand, suggesting that Elk and related polypeptides function as ligand-dependent receptor tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413296      PMCID: PMC364768          DOI: 10.1128/mcb.13.11.7071-7079.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation.

Authors:  C H Heldin; A Ernlund; C Rorsman; L Rönnstrand
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

Review 2.  The epidermal growth factor receptor as a multifunctional allosteric protein.

Authors:  J Schlessinger
Journal:  Biochemistry       Date:  1988-05-03       Impact factor: 3.162

3.  Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor.

Authors:  J A Escobedo; P J Barr; L T Williams
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

4.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

5.  Tyrosine kinase activity is essential for the association of phospholipase C-gamma with the epidermal growth factor receptor.

Authors:  B Margolis; F Bellot; A M Honegger; A Ullrich; J Schlessinger; A Zilberstein
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

6.  Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine.

Authors:  M P Kamps; B M Sefton
Journal:  Oncogene       Date:  1988-04       Impact factor: 9.867

7.  Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent.

Authors:  C Cochet; O Kashles; E M Chambaz; I Borrello; C R King; J Schlessinger
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

8.  Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors.

Authors:  H Riedel; T J Dull; A M Honegger; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

9.  HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.

Authors:  J Lee; T J Dull; I Lax; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

10.  A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.

Authors:  H Lehväslaiho; L Lehtola; L Sistonen; K Alitalo
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

View more
  6 in total

1.  Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk.

Authors:  B D Bennett; F C Zeigler; Q Gu; B Fendly; A D Goddard; N Gillett; W Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

2.  Two chimeric receptors of epidermal growth factor receptor and c-Ros that differ in their transmembrane domains have opposite effects on cell growth.

Authors:  Q Xiong; J L Chan; C S Zong; L H Wang
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.

Authors:  S J Holland; N W Gale; G D Gish; R A Roth; Z Songyang; L C Cantley; M Henkemeyer; G D Yancopoulos; T Pawson
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

Review 4.  Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases.

Authors:  Jin Chen
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

5.  Membrane-bound LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases.

Authors:  R Brambilla; A Schnapp; F Casagranda; J P Labrador; A D Bergemann; J G Flanagan; E B Pasquale; R Klein
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

6.  Localized Bicaudal-C RNA encodes a protein containing a KH domain, the RNA binding motif of FMR1.

Authors:  M Mahone; E E Saffman; P F Lasko
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.